Novo Nordisk A/S total revenue, net income and dynamics of changes in Euro today
Novo Nordisk A/S revenue for the past few reporting periods. Net income Novo Nordisk A/S - 12 623 000 000 €. Information about net income is used from open sources. The dynamics of Novo Nordisk A/S net income went up. The change was 3 305 000 000 €. Novo Nordisk A/S online financial report chart. The financial report chart shows the values from 31/03/2019 to 31/03/2021. All information on Novo Nordisk A/S total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
31 571 719 056 €
+15.41 % ↑
11 789 427 572 €
+20.85 % ↑
31/12/2020
30 015 735 032 €
-0.861 % ↓
8 702 676 552 €
+6.89 % ↑
30/09/2020
28 884 704 628 €
+2.15 % ↑
9 617 961 272 €
+1.02 % ↑
30/06/2020
28 024 523 784 €
-0.0999 % ↓
9 923 367 500 €
+10.73 % ↑
31/12/2019
30 276 310 988 €
-
8 141 364 188 €
-
30/09/2019
28 277 628 028 €
-
9 520 829 016 €
-
30/06/2019
28 052 542 704 €
-
8 961 384 580 €
-
31/03/2019
27 356 739 524 €
-
9 755 253 980 €
-
Show:
to
Novo Nordisk A/S financial report charts
The latest dates of Novo Nordisk A/S financial statements available online: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Novo Nordisk A/S is 31/03/2021. Gross profit Novo Nordisk A/S is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Novo Nordisk A/S is 27 993 000 000 €
Novo Nordisk A/S quarterly report dates
Cost of revenue Novo Nordisk A/S is the total cost of producing and distributing of products and services of a company. Cost of revenue Novo Nordisk A/S is 5 811 000 000 € Total revenue Novo Nordisk A/S refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Novo Nordisk A/S is 33 804 000 000 € Operating income Novo Nordisk A/S is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Novo Nordisk A/S is 14 982 000 000 €
Net income Novo Nordisk A/S is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Novo Nordisk A/S is 12 623 000 000 € Current assets Novo Nordisk A/S is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Novo Nordisk A/S is 61 389 000 000 € Total assets Novo Nordisk A/S refers to the total amount of assets owned by a person or entity. Total assets Novo Nordisk A/S is 141 387 000 000 €
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
26 144 454 252 €
24 767 791 316 €
24 070 120 208 €
23 567 647 576 €
25 697 085 496 €
23 537 760 728 €
23 523 751 268 €
22 937 221 876 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
5 427 264 804 €
5 247 943 716 €
4 814 584 420 €
4 456 876 208 €
4 579 225 492 €
4 739 867 300 €
4 528 791 436 €
4 419 517 648 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
31 571 719 056 €
30 015 735 032 €
28 884 704 628 €
28 024 523 784 €
30 276 310 988 €
28 277 628 028 €
28 052 542 704 €
27 356 739 524 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
13 992 648 648 €
10 766 736 992 €
11 962 210 912 €
12 924 193 832 €
12 003 305 328 €
12 065 880 916 €
12 563 683 728 €
13 298 713 396 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
11 789 427 572 €
8 702 676 552 €
9 617 961 272 €
9 923 367 500 €
8 141 364 188 €
9 520 829 016 €
8 961 384 580 €
9 755 253 980 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
3 683 554 016 €
3 860 073 212 €
3 652 733 204 €
3 073 675 524 €
3 674 214 376 €
3 363 204 364 €
3 322 109 948 €
2 501 155 592 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
17 579 070 408 €
19 248 998 040 €
16 922 493 716 €
15 100 329 952 €
18 273 005 660 €
16 211 747 112 €
15 488 858 976 €
14 058 026 128 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
57 335 115 996 €
61 463 236 876 €
68 802 325 988 €
68 720 137 156 €
58 331 655 584 €
59 213 317 600 €
54 842 366 080 €
49 251 657 576 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
132 050 368 068 €
135 351 930 808 €
130 705 459 908 €
127 132 113 644 €
117 317 085 968 €
116 659 575 312 €
110 122 761 276 €
102 862 125 140 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
5 307 717 412 €
11 914 578 748 €
23 797 402 720 €
23 231 420 536 €
14 453 092 900 €
17 518 362 748 €
13 502 317 548 €
8 457 044 020 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
55 087 998 612 €
58 920 986 868 €
52 857 692 580 €
51 143 868 640 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
63 527 297 316 €
67 203 379 620 €
60 543 282 336 €
58 667 882 624 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
54.15 %
57.61 %
54.98 %
57.04 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
54 633 158 144 €
59 143 270 300 €
55 639 037 372 €
56 088 274 056 €
53 789 788 652 €
49 456 195 692 €
49 579 478 940 €
44 194 242 516 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
4 823 924 060 €
15 585 991 232 €
14 045 884 596 €
9 236 903 960 €
Last revenue report of Novo Nordisk A/S was 31/03/2021. According to last financial report total revenue in Novo Nordisk A/S was 31 571 719 056 Euro and changed by +15.41% since last year. Net income in Novo Nordisk A/S was 11 789 427 572 € in last quartal, net income changes to +20.85%.
Current cash Novo Nordisk A/S - the sum of all of the cash a company has on the date of report. Current cash Novo Nordisk A/S is 5 683 000 000 €
Novo Nordisk A/S stocks data
NOVA.DE stock price
Novo Nordisk A/S stock price today, NOVA.DE stock quote.
